Developing AI-Based Assessments for TIL Scoring in Melanoma and Beyond
An artificial intelligence (AI)–driven assessment of tumor-infiltrating lymphocytes (TILs) may show superiority to pathologist-read scoring among patients undergoing…
Browsing Category